Munro Partners Boosts Holdings in Linde PLC $LIN

Munro Partners raised its position in Linde PLC (NASDAQ:LIN) by 5.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 43,139 shares of the basic materials company’s stock after acquiring an additional 2,325 shares during the period. Munro Partners’ holdings in Linde were worth $20,491,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also made changes to their positions in the business. Darwin Wealth Management LLC acquired a new stake in shares of Linde in the 2nd quarter worth $25,000. eCIO Inc. purchased a new stake in Linde in the first quarter valued at about $45,000. Howard Hughes Medical Institute acquired a new stake in Linde in the second quarter worth about $48,000. Nova Wealth Management Inc. purchased a new stake in shares of Linde during the first quarter worth about $52,000. Finally, Activest Wealth Management increased its holdings in shares of Linde by 5,800.0% during the first quarter. Activest Wealth Management now owns 118 shares of the basic materials company’s stock valued at $55,000 after acquiring an additional 116 shares in the last quarter. 82.80% of the stock is owned by institutional investors and hedge funds.

Linde Stock Up 0.4%

NASDAQ:LIN opened at $425.10 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.82 and a quick ratio of 0.69. The company’s fifty day moving average price is $421.11 and its 200-day moving average price is $453.39. Linde PLC has a 1-year low of $387.78 and a 1-year high of $486.38. The firm has a market capitalization of $198.50 billion, a P/E ratio of 28.47, a PEG ratio of 3.25 and a beta of 0.85.

Linde (NASDAQ:LIN) last posted its quarterly earnings results on Friday, October 31st. The basic materials company reported $4.21 EPS for the quarter, beating the consensus estimate of $4.18 by $0.03. The company had revenue of $8.62 billion for the quarter, compared to analyst estimates of $8.62 billion. Linde had a net margin of 21.17% and a return on equity of 19.38%. The firm’s revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the company earned $3.94 earnings per share. Linde has set its FY 2025 guidance at 16.350-16.450 EPS and its Q4 2025 guidance at 4.100-4.200 EPS. As a group, equities research analysts anticipate that Linde PLC will post 16.54 EPS for the current year.

Linde Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 17th. Investors of record on Wednesday, December 3rd were issued a dividend of $1.50 per share. This represents a $6.00 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend was Wednesday, December 3rd. Linde’s dividend payout ratio (DPR) is 40.19%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. Seaport Res Ptn upgraded shares of Linde from a “hold” rating to a “strong-buy” rating in a research note on Monday, November 3rd. UBS Group reaffirmed a “buy” rating on shares of Linde in a report on Friday, December 12th. Royal Bank Of Canada dropped their price objective on shares of Linde from $540.00 to $490.00 and set an “outperform” rating on the stock in a report on Friday, December 12th. CICC Research initiated coverage on Linde in a research report on Wednesday, December 3rd. They issued an “outperform” rating and a $510.00 target price on the stock. Finally, BMO Capital Markets set a $501.00 price target on Linde in a research report on Wednesday, December 17th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, Linde currently has a consensus rating of “Buy” and an average price target of $501.00.

About Linde

Linde (NASDAQ: LIN) is a multinational industrial gases and engineering company that supplies gases, related technologies and services to a wide range of industries. The company traces its current form to the 2018 combination of Germany’s Linde AG and U.S.-based Praxair, creating one of the largest global providers of industrial, specialty and medical gases. Linde’s business model centers on production, processing and distribution of gases as well as the design and construction of the plants and equipment needed to produce them.

Core products and services include atmospheric and process gases such as oxygen, nitrogen and argon; hydrogen and helium; carbon dioxide; and a portfolio of higher‑value specialty and electronic gases.